Penicillin De-labeling in the Pediatric Primary Care Setting

Status Completed

Clinical Trial Summary

While reported adverse reactions to penicillins are common, most patients with a penicillin allergy label can safely tolerate penicillins, and elective evaluation for penicillin allergy has been recommended. For low-risk patients, direct oral challenge may be an optimal approach as a delabeling strategy. However, there is a vast disparity between the number of patients with a penicillin allergy label and practicing allergists in the United States, and implementing outpatient primary care-based delabeling strategies in low-risk patients may increase access to delabeling assessments. However, a recent survey of pediatricians identified perceived barriers to implementing penicillin allergy evaluations into their routine care. Significant gaps in knowledge exist regarding the feasibility of this approach involving risk stratification evaluation of reported penicillin adverse reactions and direct amoxicillin challenge procedures in low-risk patients in the pediatric primary care setting. With this, the primary aim of this study is to evaluate the number of patients for which risk-stratification and direct amoxicillin challenge are successfully completed in an outpatient pediatric primary care clinic.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05010304
Study type	Interventional
Source	University of Texas Southwestern Medical Center
Contact
Status	Completed
Phase	Phase 4
Start date	December 9, 2021
Completion date	November 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT05563610` - Oral Penicillin Challenge and Allergy De-labeling in Children	Phase 4
Completed	`NCT05020327` - Inpatient Penicillin Allergy Delabeling Study	Phase 4
Completed	`NCT04441021` - Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy
Not yet recruiting	`NCT05956080` - Penicillin Allergy Delabeling Among Surgical Patients	N/A
Recruiting	`NCT03757052` - Amoxicillin Challenge for Penicillin Allergy Diagnosis	N/A
Completed	`NCT03702270` - The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal	N/A
Recruiting	`NCT05464615` - Geisinger Antibiotic Allergy Pilot Program: Assess and Address	Early Phase 1
Completed	`NCT03702283` - Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal in ICU Setting	N/A
Not yet recruiting	`NCT03499457` - Penicillin Allergy in Shfayim Clinic	N/A
Completed	`NCT01667055` - The Diagnosis of Beta-lactam Hypersensitivity in Thailand
Withdrawn	`NCT00589251` - Equivalency of Penicilloate Skin Test Reactivity Prepared by a Modified Alkaline Hydrolysis Technique	N/A
Completed	`NCT04620746` - Penicillin Allergy Testing in STD Clinics	Phase 4
Completed	`NCT05090527` - Penicillin Allergy Delabeling Project	N/A
Completed	`NCT03033394` - Beta-lactam Pharmacokinetics in Secondary Care
Completed	`NCT02036840` - Perioperative Antibiotic Choices for Surgical Prophylaxis in Penicillin-allergic Pediatric Patients	N/A
Terminated	`NCT00363688` - Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin	Phase 4
Completed	`NCT03158831` - Drug Challenges Without Prior Skin Testing	Phase 1
Recruiting	`NCT06303128` - Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge	Phase 3
Completed	`NCT03942731` - Penicillin Allergy Testing and Resensitization Rate
Completed	`NCT03404804` - Oral Challenge in the Pediatric ED	Phase 4